MedTrace Logo

Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation

NCT02725008 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2019-02-27

Study results available
· View outcomes & findings →

Summary

Comparing one versus two doses of oral dexamethasone for the treatment of asthma in the pediatric emergency department.

Conditions

Interventions

DRUG

Dexamethasone

DRUG

placebo

to be given to the experimental group on the day after discharge from the ED in lieu of the second dose of dexamethasone

Sponsors & Collaborators

  • Geoffrey W Jara-Almonte

    lead OTHER

Principal Investigators

  • Christopher Kelly, MD · New York Presbyterian Brooklyn Methodist Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Months
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02725008 on ClinicalTrials.gov